
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI
[ Mon, Apr 15th 2019 ]: WOPRAI

[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI
[ Fri, Apr 12th 2019 ]: WOPRAI

[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI
[ Thu, Apr 11th 2019 ]: WOPRAI

[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI
[ Wed, Apr 10th 2019 ]: WOPRAI

[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
[ Tue, Apr 09th 2019 ]: WOPRAI
Liav Abraham Maintained (TEVA) at Strong Buy with Decreased Target to $23 on, Apr 11th, 2019


🞛 This publication is a summary or evaluation of another publication
Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Decreased Target from $27 to $23 on, Apr 11th, 2019.
Liav has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 4 agree with Liav's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $18 on, Wednesday, April 3rd, 2019
- David Risinger of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $17 on, Wednesday, March 6th, 2019
- Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
- David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019
These are the ratings of the 2 analyists that currently disagree with Liav
- Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019
- Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
Similar Stocks and Investing Publications
[ Wed, Apr 03rd 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Thu, Feb 14th 2019 ]: WOPRAI
[ Thu, Feb 14th 2019 ]: WOPRAI
[ Thu, May 31st 2018 ]: WOPRAI
[ Mon, May 07th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Tue, Jan 09th 2018 ]: WOPRAI
[ Fri, Jun 09th 2017 ]: WOPRAI